These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 27035961

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1X.
    Kagiava A, Richter J, Tryfonos C, Karaiskos C, Heslegrave AJ, Sargiannidou I, Rossor AM, Zetterberg H, Reilly MM, Christodoulou C, Kleopa KA.
    Hum Mol Genet; 2019 Nov 01; 28(21):3528-3542. PubMed ID: 31411673
    [Abstract] [Full Text] [Related]

  • 3. AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy.
    Kagiava A, Karaiskos C, Richter J, Tryfonos C, Jennings MJ, Heslegrave AJ, Sargiannidou I, Stavrou M, Zetterberg H, Reilly MM, Christodoulou C, Horvath R, Kleopa KA.
    Gene Ther; 2021 Nov 01; 28(10-11):659-675. PubMed ID: 33692503
    [Abstract] [Full Text] [Related]

  • 4. Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathy.
    Schiza N, Georgiou E, Kagiava A, Médard JJ, Richter J, Tryfonos C, Sargiannidou I, Heslegrave AJ, Rossor AM, Zetterberg H, Reilly MM, Christodoulou C, Chrast R, Kleopa KA.
    Brain; 2019 May 01; 142(5):1227-1241. PubMed ID: 30907403
    [Abstract] [Full Text] [Related]

  • 5. Intraneural GJB1 gene delivery improves nerve pathology in a model of X-linked Charcot-Marie-Tooth disease.
    Sargiannidou I, Kagiava A, Bashiardes S, Richter J, Christodoulou C, Scherer SS, Kleopa KA.
    Ann Neurol; 2015 Aug 01; 78(2):303-16. PubMed ID: 26010264
    [Abstract] [Full Text] [Related]

  • 6. Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice.
    Scherer SS, Xu YT, Messing A, Willecke K, Fischbeck KH, Jeng LJ.
    J Neurosci; 2005 Feb 09; 25(6):1550-9. PubMed ID: 15703409
    [Abstract] [Full Text] [Related]

  • 7. Intrathecal gene therapy in mouse models expressing CMT1X mutations.
    Kagiava A, Karaiskos C, Richter J, Tryfonos C, Lapathitis G, Sargiannidou I, Christodoulou C, Kleopa KA.
    Hum Mol Genet; 2018 Apr 15; 27(8):1460-1473. PubMed ID: 29462293
    [Abstract] [Full Text] [Related]

  • 8. Gene therapy approaches targeting Schwann cells for demyelinating neuropathies.
    Sargiannidou I, Kagiava A, Kleopa KA.
    Brain Res; 2020 Feb 01; 1728():146572. PubMed ID: 31790684
    [Abstract] [Full Text] [Related]

  • 9. Gene expression profiling studies in regenerating nerves in a mouse model for CMT1X: uninjured Cx32-knockout peripheral nerves display expression profile of injured wild type nerves.
    Freidin M, Asche-Godin S, Abrams CK.
    Exp Neurol; 2015 Jan 01; 263():339-49. PubMed ID: 25447941
    [Abstract] [Full Text] [Related]

  • 10. Gene replacement therapy in two Golgi-retained CMT1X mutants before and after the onset of demyelinating neuropathy.
    Kagiava A, Karaiskos C, Lapathitis G, Heslegrave A, Sargiannidou I, Zetterberg H, Bosch A, Kleopa KA.
    Mol Ther Methods Clin Dev; 2023 Sep 14; 30():377-393. PubMed ID: 37645436
    [Abstract] [Full Text] [Related]

  • 11. Molecular genetics of X-linked Charcot-Marie-Tooth disease.
    Kleopa KA, Scherer SS.
    Neuromolecular Med; 2006 Sep 14; 8(1-2):107-22. PubMed ID: 16775370
    [Abstract] [Full Text] [Related]

  • 12. Axonal pathology precedes demyelination in a mouse model of X-linked demyelinating/type I Charcot-Marie Tooth neuropathy.
    Vavlitou N, Sargiannidou I, Markoullis K, Kyriacou K, Scherer SS, Kleopa KA.
    J Neuropathol Exp Neurol; 2010 Sep 14; 69(9):945-58. PubMed ID: 20720503
    [Abstract] [Full Text] [Related]

  • 13. A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice.
    Stavrou M, Kagiava A, Choudury SG, Jennings MJ, Wallace LM, Fowler AM, Heslegrave A, Richter J, Tryfonos C, Christodoulou C, Zetterberg H, Horvath R, Harper SQ, Kleopa KA.
    J Clin Invest; 2022 Jul 01; 132(13):. PubMed ID: 35579942
    [Abstract] [Full Text] [Related]

  • 14. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
    Klein D, Patzkó Á, Schreiber D, van Hauwermeiren A, Baier M, Groh J, West BL, Martini R.
    Brain; 2015 Nov 01; 138(Pt 11):3193-205. PubMed ID: 26297559
    [Abstract] [Full Text] [Related]

  • 15. Pmp22 mutant allele-specific siRNA alleviates demyelinating neuropathic phenotype in vivo.
    Lee JS, Chang EH, Koo OJ, Jwa DH, Mo WM, Kwak G, Moon HW, Park HT, Hong YB, Choi BO.
    Neurobiol Dis; 2017 Apr 01; 100():99-107. PubMed ID: 28108290
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Myelin abnormality in Charcot-Marie-Tooth type 4J recapitulates features of acquired demyelination.
    Hu B, McCollum M, Ravi V, Arpag S, Moiseev D, Castoro R, Mobley B, Burnette B, Siskind C, Day J, Yawn R, Feely S, Li Y, Yan Q, Shy M, Li J.
    Ann Neurol; 2018 Apr 01; 83(4):756-770. PubMed ID: 29518270
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Two new mouse models of Gjb1-associated Charcot-Marie-Tooth disease type 1X.
    Tadenev ALD, Hatton CL, Pattavina B, Mullins T, Schneider R, Bogdanik LP, Burgess RW.
    J Peripher Nerv Syst; 2023 Sep 01; 28(3):317-328. PubMed ID: 37551045
    [Abstract] [Full Text] [Related]

  • 20. Phosphorylation of eIF2α Promotes Schwann Cell Differentiation and Myelination in CMT1B Mice with Activated UPR.
    Scapin C, Ferri C, Pettinato E, Bianchi F, Del Carro U, Feltri ML, Kaufman RJ, Wrabetz L, D'Antonio M.
    J Neurosci; 2020 Oct 14; 40(42):8174-8187. PubMed ID: 32973043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.